Assessment of measles incidence, measles-related complications and hospitalisations during an outbreak in a southern Italian region

被引：17
作者：
degli Atti, MLC
Filia, A
Massari, M
Pizzuti, R
Nicoletti, L
D'Argenzio, A
de Campora, E
Marchi, A
Lombardo, A
Salmaso, S
机构：
[1] Ist Super Sanita, Ctr Nazl Epidemiol Sorveglianza & Promoz Salute, Reparto Epidemiol Malattie Infett, I-00161 Rome, Italy
[2] Osservatorio Epidemiol Reg, Naples, Italy
[3] Ist Super Sanita, Dipartimento Malattie Infett, Reparto Malattie Virali & Vaccini Attenuati, I-00161 Rome, Italy
[4] ASL Caserta 2, Aversa, Italy
[5] Agenzia Reg Serv Sanitari, Naples, Italy
来源：
VACCINE | 2006年 / 24卷 / 09期
关键词：
measles epidemic; surveillance; vaccination;
D O I：
10.1016/j.vaccine.2005.09.031
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A large measles epidemic occurred in 2002 in Campania, a region of southern Italy with inadequate vaccination coverage. We evaluated the burden of the outbreak in children < 15 years of age using different data sources. The measles standardized incidence rate was 5757/100,000, corresponding to 63,368 estimated cases (95% CI: 59,544-67,373). Measles virus strains were identified as belonging to the D7 genotype. The estimated complication rate was 7.6%. A total of 972 measles hospitalisations were detected, giving a hospitalisation rate of 88.3/100,000. Three deaths occurred. These results show that measles can still represent a serious health threat even in industrialized Countries. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1332 / 1338
页数：7
相关论文
共 28 条
  • [1] [Anonymous], 1994, Bull World Health Organ, V72, P885
  • [2] [Anonymous], STRAT PLAN MEASL CON
  • [3] Do changes in policy affect vaccine coverage levels? Results of a national study to evaluate childhood vaccination coverage and reasons for missed vaccination in Italy
    Atti, MLC
    Rota, MC
    Bella, A
    Salmaso, S
    Binkin, N
    Perra, A
    Bellomo, AR
    Di Giorgio, G
    Fiumalbi, C
    Frizza, J
    Frongia, O
    Cassiani, R
    Salvadei, M
    Cauzillo, G
    Locuratolo, F
    De Filippis, S
    Basile, C
    Pizzuti, R
    Romagna, E
    Grandori, L
    Ancarani, C
    Bertozzi, N
    Tominz, R
    Pompa, MG
    Bellomo, AR
    Ciuta, ST
    Crovari, P
    Icardi, GC
    De Luca, S
    Sensi, S
    Sebastiani, E
    Frizza, J
    Grilli, G
    Carducci, E
    Di Giorgio, G
    Kreidl, P
    Foppa, A
    Gamper, S
    Weiss, S
    Carraro, V
    Barale, A
    Lopalco, P
    Prato, R
    Novelli, G
    Fiongia, O
    Scondotto, S
    Di Giorgi, M
    Cernigliaro, A
    Fiumalbi, C
    Bidini, G
    [J]. VACCINE, 2004, 22 (31-32) : 4351 - 4357
  • [4] Atti MLCD, 2002, PEDIATR INFECT DIS J, V21, P763, DOI [10.1097/01.inf.0000023961.12041.2b, 10.1097/00006454-200208000-00013]
  • [5] BARON S, 1996, REV EPIDEMIOL SANTE, V44, pS19
  • [6] BOVE C, 2002, BEN MARZO
  • [7] SALIVARY DIAGNOSIS OF MEASLES - A STUDY OF NOTIFIED CASES IN THE UNITED-KINGDOM, 1991-3
    BROWN, DWG
    RAMSAY, MEB
    RICHARDS, AF
    MILLER, E
    [J]. BRITISH MEDICAL JOURNAL, 1994, 308 (6935) : 1015 - 1017
  • [8] The average cost of measles cases and adverse events following vaccination in industrialised countries
    Carabin, H
    Edmunds, WJ
    Kou, U
    van den Hof, S
    Nguyen, VH
    [J]. BMC PUBLIC HEALTH, 2002, 2 (1) : 1 - 13
  • [9] DEGLIATTI MLC, 2003, MMWR-MORBID MORTAL W, V52, P1044
  • [10] FILIA A, 2005, RAPPORTI ISTISAN, V5
123